Is BMY or ELV cheaper?

On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and ELV at 17.19.

Which has grown faster, BMY or ELV?

Over the past five years, ELV grew revenue faster — BMY at a 2.52% CAGR versus ELV at 9.97%.

Does BMY or ELV pay a bigger dividend?

BMY yields 4.38% and ELV yields 1.70% based on trailing dividends and the latest price.

Is BMY or ELV more profitable?

BMY runs the higher net margin — BMY at 15.01% versus ELV at 2.62%.

Which has been the better investment, BMY or ELV?

Over the past 10-year, ELV delivered the higher annualized total return — BMY at 1.08% versus ELV at 13.43%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Elevance Health Inc. (ELV)

BMY leads on 13 of 17 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs ELV

growth of $100 · last 25y

BMY +4.1%ELV +1875.9%ELV compounded faster

Log scale — wide-divergence pair

BMY ELV

BMY vs ELV: by the numbers

•BMY is the larger company ($116.66B vs $87.75B market cap).
•BMY trades at the lower earnings multiple (16.05 vs 17.19 P/E).
•BMY converts more revenue to profit (15.01% vs 2.62% net margin).
•ELV grew revenue faster over the past five years (9.97% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.38% vs 1.70%).

Which is better, BMY or ELV?

Metric tally: BMY 13 · ELV 4

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthELV(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityBMY(higher ROIC)

Valuation

Metric	BMY	ELV
P/E ratio	16.05●	17.19
Forward P/E	9.31●	13.82
P/S ratio	2.41	0.44●
P/B ratio	5.82	2.03●
PEG ratio	1.71●	2.58
EV / EBITDA	11.03●	12.48
FCF yield	10.20%●	7.24%

Profitability

Metric	BMY	ELV
Gross margin	68.75%●	23.16%
Operating margin	25.67%●	3.81%
Net margin	15.01%●	2.62%
ROE	36.25%●	11.94%
ROIC	13.90%●	6.65%

Dividends

Metric	BMY	ELV
Dividend yield	4.38%●	1.70%
Payout ratio	72.25%	27.24%

Growth (annualized)

Metric	BMY	ELV
Revenue CAGR (5Y)	2.52%	9.97%●
EPS CAGR (5Y)	9.38%●	6.67%
FCF CAGR (5Y)	-2.50%●	-7.76%
Total return CAGR (5Y)	0.74%	2.50%●

Frequently asked

Which is better, BMY or ELV?: It depends on your goal. value: BMY (lower P/E); growth: ELV (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 13 to 4.
Is BMY or ELV cheaper?: On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and ELV at 17.19.
Which has grown faster, BMY or ELV?: Over the past five years, ELV grew revenue faster — BMY at a 2.52% CAGR versus ELV at 9.97%.
Does BMY or ELV pay a bigger dividend?: BMY yields 4.38% and ELV yields 1.70% based on trailing dividends and the latest price.
Is BMY or ELV more profitable?: BMY runs the higher net margin — BMY at 15.01% versus ELV at 2.62%.
Which has been the better investment, BMY or ELV?: Over the past 10-year, ELV delivered the higher annualized total return — BMY at 1.08% versus ELV at 13.43%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full ELV analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Elevance Health P/E ratio Bristol-Myers Squibb dividend yield Elevance Health dividend yield Bristol-Myers Squibb ROE Elevance Health ROE Bristol-Myers Squibb operating margin Elevance Health operating margin Bristol-Myers Squibb revenue growth Elevance Health revenue growth Bristol-Myers Squibb free cash flow Elevance Health free cash flow

Bristol-Myers Squibb & Elevance Health appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.